Environmental Light Has an Essential Effect on the Disease Expression in a Dominant RPE65 Mutation

  • Conference paper
  • First Online:
Retinal Degenerative Diseases XIX

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 1415))

  • 1548 Accesses

Abstract

The retina pigmented epithelium 65 kDa protein (RPE65) is an essential enzyme in the visual cycle that regenerates the 11-cis-retinal chromophore obligatory for vision. Mutations in RPE65 are associated with blinding diseases. D477G (C.1430G > A) is the only known RPE65 variant to cause autosomal dominant retinitis pigmentosa (adRP). Previously, we reported that the heterozygous D477G knock-in (WT/KI) mice exposed to dim light intensity demonstrated delayed chromophore regeneration rates and slowed recovery of photoreceptor sensitivity following photobleaching. However, visual function and retinal architecture were indistinguishable from the wild-type (WT) mice. In this study, when maintained under the physiological day-light intensity (2 K lux), the WT/KI heterozygous mice displayed retina degeneration and reduced electroretinography (ERG) amplitude, recapitulating that observed in human patients. Our findings indicated the importance of the light environment in the mechanism of RPE65 D477G pathogenicity.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
EUR 29.95
Price includes VAT (Germany)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
EUR 319.93
Price includes VAT (Germany)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
EUR 406.59
Price includes VAT (Germany)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Aoun M, Passerini I, Chiurazzi P, Karali M, De Rienzo I, Sartor G, et al. Inherited retinal diseases due to RPE65 variants: from genetic diagnostic management to therapy. Int J Mol Sci. 2021;22(13):7207.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Bowne SJ, Humphries MM, Sullivan LS, Kenna PF, Tam LCS, Kiang AS, et al. A dominant mutation in RPE65 identified by whole-exome sequencing causes retinitis pigmentosa with choroidal involvement. Eur J Hum Genet. 2011;19(10):1074–81.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Cai X, Conley SM, Naash MI. RPE65: role in the visual cycle, human retinal disease, and gene therapy. Ophthalmic Genet. 2009;30(2):57–62.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Cremers FPM, Boon CJF, Bujakowska K, Zeitz C. Special issue introduction: inherited retinal disease: novel candidate genes, genotype-phenotype correlations, and inheritance models. Genes (Basel). 2018;9(4):215.

    Article  PubMed  Google Scholar 

  5. Galvin JA, Fishman GA, Stone EM, Koenekoop RK. Evaluation of genotype-phenotype associations in leber congenital amaurosis. Retina (Philadelphia, Pa). 2005;25(7):919–29.

    Article  PubMed  Google Scholar 

  6. Hull S, Mukherjee R, Holder GE, Moore AT, Webster AR. The clinical features of retinal disease due to a dominant mutation in RPE65. Mol Vis. 2016;22:626–35.

    CAS  PubMed  PubMed Central  Google Scholar 

  7. Jauregui R, Park KS, Tsang SH. Two-year progression analysis of RPE65 autosomal dominant retinitis pigmentosa. Ophthalmic Genet. 2018;39(4):544–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Kenna PF, Humphries MM, Kiang A-S, Brabet P, Guillou L, Ozaki E, et al. Advanced late-onset retinitis pigmentosa with dominant-acting D477G RPE65 mutation is responsive to oral synthetic retinoid therapy. BMJ Open Ophthalmol. 2020;5(1):e000462-e.

    Article  Google Scholar 

  9. Kiang AS, Kenna PF, Humphries MM, Ozaki E, Koenekoop RK, Campbell M, et al. Properties and therapeutic implications of an enigmatic D477G RPE65 variant associated with autosomal dominant retinitis pigmentosa. Genes (Basel). 2020;11(12):1420.

    Article  CAS  PubMed  Google Scholar 

  10. Li Y, Furhang R, Ray A, Duncan T, Soucy J, Mahdi R, et al. Aberrant RNA splicing is the major pathogenic effect in a knock-in mouse model of the dominantly inherited c.1430A>G human RPE65 mutation. Hum Mutat. 2019;40(4):426–43.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Ma X, Takahashi Y, Wu W, Liang W, Chen J, Chakraborty D, et al. ADAM17 mediates ectodomain shedding of the soluble VLDL receptor fragment in the retinal epithelium. J Biol Chem. 2021;297(4):101185.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Qiu F, Ma X, Shin Y-H, Chen J, Chen Q, Zhou K, et al. Pathogenic role of human C-reactive protein in diabetic retinopathy. Clin Sci. 2020;134(13):1613–29.

    Article  CAS  Google Scholar 

  13. Qiu F, Meng T, Chen Q, Zhou K, Shao Y, Matlock G, et al. Fenofibrate-loaded biodegradable nanoparticles for the treatment of experimental diabetic retinopathy and neovascular age-related macular degeneration. Mol Pharm. 2019;16(5):1958–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Redmond TM, Yu S, Lee E, Bok D, Hamasaki D, Chen N, et al. Rpe65 is necessary for production of 11-cis-vitamin A in the retinal visual cycle. Nat Genet. 1998;20(4):344–51.

    Article  CAS  PubMed  Google Scholar 

  15. Shin Y, Moiseyev G, Chakraborty D, Ma J-X. A dominant mutation in Rpe65, D477G, delays dark adaptation and disturbs the visual cycle in the mutant knock-in mice. Am J Pathol. 2017;187(3):517–27.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Thompson DA, Gyürüs P, Fleischer LL, Bingham EL, McHenry CL, Apfelstedt-Sylla E, et al. Genetics and phenotypes of RPE65 mutations in inherited retinal degeneration. Invest Ophthalmol Vis Sci. 2000;41(13):4293–9.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors are grateful to the OUSHC animal husbandry team for their diligence and devotion to the well-being of all our mice. This study is supported by the National Institutes of Health (NIH) grants (EY018659, EY019309, EY012231, EY028949, EY032930, EY032931).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Gennadiy Moiseyev or Jian-**ng Ma .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this paper

Check for updates. Verify currency and authenticity via CrossMark

Cite this paper

Wu, W., Takahashi, Y., Ma, X., Moiseyev, G., Ma, JX. (2023). Environmental Light Has an Essential Effect on the Disease Expression in a Dominant RPE65 Mutation. In: Ash, J.D., Pierce, E., Anderson, R.E., Bowes Rickman, C., Hollyfield, J.G., Grimm, C. (eds) Retinal Degenerative Diseases XIX. Advances in Experimental Medicine and Biology, vol 1415. Springer, Cham. https://doi.org/10.1007/978-3-031-27681-1_61

Download citation

Publish with us

Policies and ethics

Navigation